AI in Healthcare November 18, 2024
Dave Pearson

Three-quarters of organizations in the life-sciences field started using AI less than two years ago. Which is to say that most only joined the party after generative AI became a thing. (Or did it become the thing?)

Whether or not the rapid ramp-up is a case of cause and effect isn’t clear. In any case, the pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

In fact, a new survey by the multinational law firm Arnold & Porter shows more than 85% of operators in this arena plan to fully deploy new AI tools over the next two years.

The report offers five observations from the survey, which queried...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Survey / Study, Technology, Trends
BCBS Massachusetts weight loss drug spend jumps 250%: 5 notes
GLP-1 reduced heart failure risk by 46%: 8 study takeaways
Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval
Future of Medicare drug price negotiations under new administration: 5 things to know
NVIDIA BioNeMo Framework Accelerates AI Drug Discovery

Share This Article